Literature DB >> 2726454

On the fidelity of mRNA translation in the nuclease-treated rabbit reticulocyte lysate system.

M C Dasso1, R J Jackson.   

Abstract

As a test of the fidelity of the rabbit reticulocyte lysate system, we have examined the products of translation of various different influenza virus mRNAs, produced by in vitro transcription. A common finding with all mRNA species was that the ratio of full-length translation product to incomplete products decreased with increasing mRNA concentration. These short products are a mixture of (i) polypeptides initiated at the authentic initiation site but terminated prematurely, and (ii) polypeptides initiated at internal sites and terminated at the correct site. Analysis of mRNA stability during the translation assay showed very little degradation, quite insufficient to be the principle cause of incomplete product synthesis. Investigation of the influence of various parameters on the ratio of full-length to incomplete products leads to the conclusion that a high fidelity of translation can be obtained provided certain precautions are followed: the use of capped, rather than uncapped, mRNAs at low concentrations, with KCl concentrations about 20 mM above the level that gives maximum incorporation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726454      PMCID: PMC317719          DOI: 10.1093/nar/17.8.3129

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Modulation of the expression of poliovirus proteins in reticulocyte lysates.

Authors:  B A Phillips; A Emmert
Journal:  Virology       Date:  1986-01-30       Impact factor: 3.616

2.  A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products.

Authors:  R J Jackson
Journal:  Virology       Date:  1986-02       Impact factor: 3.616

3.  [An inhibitor of pancreatic ribonuclease from red blood cells].

Authors:  H Priess; W Zillig
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1967-07

4.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 5.  Structure and function of the influenza virus genome.

Authors:  J W McCauley; B W Mahy
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

6.  In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate.

Authors:  A J Dorner; B L Semler; R J Jackson; R Hanecak; E Duprey; E Wimmer
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Use of a cDNA clone to identify a supposed precursor protein containing valosin.

Authors:  K J Koller; M J Brownstein
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

9.  A rabbit reticulocyte factor which stimulates protein synthesis in several mammalian cell-free systems.

Authors:  S J Morley; W J Buhl; R J Jackson
Journal:  Biochim Biophys Acta       Date:  1985-05-24

10.  The chicken progesterone receptor: sequence, expression and functional analysis.

Authors:  H Gronemeyer; B Turcotte; C Quirin-Stricker; M T Bocquel; M E Meyer; Z Krozowski; J M Jeltsch; T Lerouge; J M Garnier; P Chambon
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  45 in total

1.  Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation.

Authors:  I K Ali; L McKendrick; S J Morley; R J Jackson
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  The KH domains of Xenopus Vg1RBP mediate RNA binding and self-association.

Authors:  Anna Git; Nancy Standart
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

3.  Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation.

Authors:  T A Pöyry; M W Hentze; R J Jackson
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

4.  Translation of the rat LINE bicistronic RNAs in vitro involves ribosomal reinitiation instead of frameshifting.

Authors:  H Ilves; O Kahre; M Speek
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

5.  Plasmid cDNA-directed protein synthesis in a coupled eukaryotic in vitro transcription-translation system.

Authors:  D Craig; M T Howell; C L Gibbs; T Hunt; R J Jackson
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

6.  Bacteriophage and spliceosomal proteins function as position-dependent cis/trans repressors of mRNA translation in vitro.

Authors:  R Stripecke; M W Hentze
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

7.  Systemic movement of an RNA plant virus determined by a point substitution in a 5' leader sequence.

Authors:  I T Petty; M C Edwards; A O Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Mechanism of initiation site selection promoted by the human rhinovirus 2 internal ribosome entry site.

Authors:  Ann Kaminski; Tuija A A Pöyry; Peter J Skene; Richard J Jackson
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

9.  Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells.

Authors:  Frederik Beaulieux; Youssef Zreik; Christelle Deleage; Valerie Sauvinet; Vincent Legay; Pascale Giraudon; Katherine M Kean; Bruno Lina
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

10.  Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.

Authors:  S N Stacey; D Jordan; P J Snijders; M Mackett; J M Walboomers; J R Arrand
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.